Align Technology ( (ALGN) ) has released its Q1 earnings. Here is a breakdown of the information Align Technology presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Align Technology, Inc. is a global medical device company specializing in the design, manufacture, and sale of the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry. The company is a leader in the digital dentistry sector, offering innovative solutions to enhance patient outcomes and practice efficiencies.
In its first-quarter 2025 earnings report, Align Technology announced total revenues of $979.3 million, marking a slight decline both sequentially and year-over-year. Despite the revenue dip, the company celebrated a significant milestone, having treated 20 million Invisalign patients, and acknowledged the continued adoption of its products in key markets.
Key financial highlights include a 6.2% year-over-year increase in Clear Aligner volume, with revenues from this segment totaling $796.8 million. The Imaging Systems and CAD/CAM Services segment saw a modest year-over-year revenue increase of 1.2%, despite a sequential decline. The company’s operating income stood at $131.1 million, with a GAAP operating margin of 13.4%, impacted by foreign exchange fluctuations. Align also reported a non-GAAP diluted net income per share of $2.13.
Looking ahead, Align Technology’s management remains optimistic, forecasting sequential revenue growth for the second quarter of 2025. The company expects continued growth in Clear Aligner volume and anticipates an increase in Systems and Services revenues as they expand their product offerings. Align aims to sustain its leadership in digital dentistry while navigating potential macroeconomic challenges.